Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 799.95
+5.45 (0.69%)
At close: Nov 6, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 198.23 billion as of November 6, 2026. It is the 6,365th most valuable company in the world and the 376th biggest in India. Its market cap has increased by 43.95% in one year.
Market Cap
198.23B
Enterprise Value
194.21B
Revenue
58.93B
Global Rank
Country Rank
#376 India
PE Ratio
28.01
ChartMarket Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 198.23B, an increase of 120,990.43%. That is a compound annual growth rate of 34.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 198.23B | 36.47% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 565.08B |
| GlaxoSmithKline Pharmaceuticals | 423.63B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Caplin Point Laboratories | 184.14B |
| AstraZeneca Pharma India | 157.37B |
| Jubilant Pharmova | 149.98B |
| Viyash Scientific | 102.79B |
| Procter & Gamble Health | 93.01B |